Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
1.
Food Res Int ; 105: 563-569, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-29433248

RESUMEN

PURPOSE: The ability of foods to aid in the prevention of chronic metabolic diseases, has recently become an area of increased interest. In addition, there is growing interest in exploring the benefits of consuming underutilized fruits as alternatives to commercially available fruits. Eugenia uvalha Cambess (uvaia) is a native fruit of Brazil with great market and phytotherapy potential. The present study was conducted to investigate the effects of uvaia juice (UJ) on the levels of protein carbonyls (PCO) and antioxidant enzymes in the livers of rats fed a high-fat diet. METHODS: Thirty-two female rats were randomly assigned to four groups. The rats were fed either a standard diet (group C) or a high-fat diet (group HF). In addition, groups CUJ and HFUJ were treated with UJ (2mL/day) administered via gavage for 8weeks. RESULTS: In our study, UJ displayed high antioxidant activity (135.14±9.74 GAE/100g). Administration of UJ caused a significantly reduced concentration of rat liver PCO (47.4%), which was associated with a 29% increase in catalase activity. A significant increase in the concentration of oxidized glutathione (GSSG) (15.04±5.08nmol/ml) and a reduction in the reduced glutathione/oxidized glutathione ratio (GSH/GSSG) (11.30±2.68) were found in the HF group, whilst these changes were not observed in the HFUJ group (a result similar to that of group C). CONCLUSIONS: Our results demonstrate that UJ decreases oxidative damage by improving antioxidant efficiency and attenuating oxidative damage to proteins.


Asunto(s)
Antioxidantes/administración & dosificación , Eugenia , Jugos de Frutas y Vegetales , Hígado/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Animales , Catalasa/metabolismo , Femenino , Glutatión/metabolismo , Hígado/enzimología , Oxidación-Reducción , Datos Preliminares , Carbonilación Proteica/efectos de los fármacos , Ratas Endogámicas F344
2.
Eur Rev Med Pharmacol Sci ; 20(13): 2872-7, 2016 07.
Artículo en Inglés | MEDLINE | ID: mdl-27424988

RESUMEN

OBJECTIVE: To assess safety, feasibility and effectiveness of transarterial chemoembolization with degradable-starch-microspheres (DSM-TACE) in the treatment of patients with advanced hepatocellular carcinoma (HCC) dismissing or ineligible for multikinase-inhibitor chemotherapy administration (Sorafenib) due to unbearable side effects or clinical contraindications. PATIENTS AND METHODS: Six consecutive advanced HCC patients dismissing Sorafenib because of unbearable side effects or worsened clinical conditions were enrolled in our prospective single-center pilot study. DSM-TACE was performed via a lobar approach, based on extent and distribution of the disease (1 treatment session for every lobe involved, with a 2-week interval in case of bilobar disease). Tumor response based on mRECIST criteria was evaluated on MD-CT performed at 1 month after "complete treatment" and every 3 months thereafter. RESULTS: Eleven treatments were performed, and technical success was achieved in all patients. No intra/peri-procedural death/major complications occurred. No signs of liver failure or systemic toxicity were detected. At one month follow-up, 5 partial responses (83.3%) and 1 progression disease (16.6%) with an overall disease control (ODC) of 83.3% were observed. In two patients with ODC and residual viable tumor higher than 50%, a repeated DSM-TACE treatment was performed. During the mean follow-up of 11 months (range: 4-14 months), an ODC of 66.6% was obtained. Progression-free survival was 5.5 months with a cumulative 6-month and 1-year overall survival rates of 83.3% and 66.6%, respectively. CONCLUSIONS: DSM-TACE seems to be a promising option for advanced HCC patients ineligible for Sorafenib administration or dismissing it due to progressive disease or unbearable side effects.


Asunto(s)
Carcinoma Hepatocelular/terapia , Quimioembolización Terapéutica , Neoplasias Hepáticas/terapia , Almidón , Carcinoma Hepatocelular/fisiopatología , Terapias Complementarias , Humanos , Neoplasias Hepáticas/fisiopatología , Proyectos Piloto
3.
J Ultrasound ; 18(3): 205-11, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26261462

RESUMEN

OBJECTIVE: The aim of this study was to determine the role of ultrasound in the diagnosis and treatment of pediatric patients with acute abdominal pain caused by intussusceptions. MATERIALS AND METHODS: We performed a retrospective study of all pediatric patients with acute abdominal pain caused by intussusceptions and that underwent ultrasound examination at the emergency service of the Radiology Department between November 2007 and June 2013. The role of ultrasonography in the diagnosis of intussusceptions has been assessed by comparing the echographic presumptive diagnosis with the final diagnosis of discharge. Its importance in the treatment has been assessed by determining the value of ultrasound findings in the choice of the best treatment. RESULTS: The ultrasound examination was positive in 16/18 patients with a final diagnosis of intussusception. Some sonographic findings seemed to be able to predict the opportunity to resort to non-surgical therapeutic options like hydrostatic or pneumatic reduction of the intestinal segments invaginated. In our casuistry, five children presented characteristics typical of this subgroup and underwent barium enema which provided the reduction of the intestinal segments involved. The future challenge will be to perform non-surgical ultrasound-guided reductions to avoid the exposure of the infants to ionizing radiations. CONCLUSIONS: Ultrasonography is essential not only in the diagnosis, but also it adds important elements in the therapeutic choice and could play in the future an important role in non-surgical reduction of intestinal intussusceptions in pediatric patients.

4.
Childs Nerv Syst ; 31(8): 1361-5, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-25930725

RESUMEN

PURPOSE: The aim of our study was to investigate the relationship between bone mineral density (BMD), vitamin D, and electrolyte blood values in patients with spina bifida, to find a possible therapeutic regimen and an intervention to reduce the risk of fractures in this population. METHODS: BMD values were measured in 49 patients (32 females, 17 males; aged 14.1 ± 3.86 years; range 5-20 years) using dual-energy X-ray absorptiometry (DEXA) and were analyzed based on sex, the level of spinal involvement, vitamin D, and electrolyte values, physical activity, body mass index (BMI), and ambulatory status [patients were divided into three subgroups: full-time wheelchair (FTWC), limited ambulator (LA), and full-time ambulator (FTA)]. These data were analyzed considering sex-, age-, and BMD-matched values and compared with those of normal population. RESULTS: BMD was significantly lower in these patients compared with that in the general healthy population (Z-score: -1.2 ± 1.8); in particular, females had Z-score values significantly lower that of the males (Z-score: -2.43 ± 2.02; P < 0.0004). In FTWC subgroup, Z-score was lower than that of the other two subgroups (P < 0.009). Vitamin D values were significantly lower compared with those in the general healthy population (vitamin D spina bifida group: 14.6 ± 8.7 mg/dL; normal subjects: 35 ± 9.8 mg/dL; P < 0.001). Subjects with spina bifida showed hypophosphatemia (<3 mg/dL) because of the lower levels of vitamin D (3.1 ± 0.9 mg/dL; P < 0.001). CONCLUSIONS: Spina bifida patients showed lower BMD, vitamin D, and electrolyte values than the healthy population; hence, they have an increase risk of developing pathological fractures. Vitamin D supplementation for a longer time period could reduce this risk.


Asunto(s)
Densidad Ósea/fisiología , Electrólitos/metabolismo , Fracturas Óseas/etiología , Fracturas Óseas/prevención & control , Disrafia Espinal/complicaciones , Disrafia Espinal/metabolismo , Vitamina D/metabolismo , Absorciometría de Fotón , Adolescente , Niño , Preescolar , Femenino , Humanos , Masculino , Adulto Joven
5.
Radiol Med ; 118(4): 555-69, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23358819

RESUMEN

PURPOSE: This study was undertaken to evaluate the feasibility, safety and efficacy of a new combined single-step therapy in patients with unresectable multinodular unilobar hepatocellular carcinoma (HCC), with at least one lesion >3 cm, with balloon-occluded radiofrequency ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) of the main lesion and TACE of the other lesions. The second purpose of our study was to compare the initial effects in terms of tumour necrosis of this new combined therapy with those obtained in a matched population treated with TACE alone in a singlestep treatment in our centre in the previous year. METHODS AND MATERIALS: This pilot study was approved by the institutional review board, and informed consent was obtained from all patients. Ten consecutive patients with multinodular (two to six nodules) unilobar unresectable HCC and with a main target lesion >3 cm (range, 3.5-6 cm) not suitable for curative therapy were enrolled in our single-centre multidisciplinary pilot study. The schedule consisted of percutaneous RFA (single 3-cm monopolar needle insertion) of the target lesion during occlusion of the hepatic artery supplying the tumour, followed by selective TACE, plus lobar TACE for other lesions (450-mg carboplatin and lipiodol plus temporary embolisation with SPONGOSTAN). Adverse events and intra- and periprocedural complications were clinically assessed. Early local efficacy was evaluated on 1-month follow-up multiphasic computed tomography (CT) on the basis of the Modified Response Evaluation Criteria in Solid Tumors (m-RECIST). A separate evaluation of target lesions in terms of enhancement, necrotic diameter and presence and distribution of lipiodol uptake was also performed. RESULTS: No major complications occurred. Overall technical success, defined as complete devascularisation of all nodules during the arterial phase, was achieved in seven of 10 patients, with three cases of partial response (persistence of small hypervascular nodules). When considering only target lesions, technical success was obtained in all patients, with a nonenhancing area corresponding in shape to the previously identified HCC (necrotic diameter, 3.5-5 cm) and with circumferential peripheral lipiodol uptake (safety margin) of at least 0.5 cm (0.5-1.3cm). CONCLUSIONS: TACE and BO-RFA, plus TACE in a singlestep approach seems to be a safe and effective combined therapy for treating advanced, unresectable HCC lesions, allowing a high rate of complete local response to be achieved in large lesions also.


Asunto(s)
Oclusión con Balón/métodos , Carcinoma Hepatocelular/terapia , Ablación por Catéter/métodos , Quimioembolización Terapéutica/métodos , Neoplasias Hepáticas/terapia , Anciano , Algoritmos , Profilaxis Antibiótica , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Carboplatino/administración & dosificación , Terapia Combinada , Aceite Etiodizado/administración & dosificación , Femenino , Esponja de Gelatina Absorbible/administración & dosificación , Humanos , Masculino , Persona de Mediana Edad , Seguridad del Paciente , Proyectos Piloto , Resultado del Tratamiento
6.
Br J Radiol ; 84(998): 112-9, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-20959377

RESUMEN

OBJECTIVE: The aim of the study is to compare CT enterography with polyethylene glycol solution (PEG-CT) with CT enteroclysis (CT-E) in patients with suspected small bowel disease. METHODS: 145 patients underwent abdominal contrast-enhanced 16-row multidetector CT after administration of 2000 ml of PEG by mouth (n = 75) or after administration of 2000 ml of methylcellulose by nasojejunal tube (n = 70). Small bowel distension, luminal and extraluminal findings were evaluated and compared with small bowel follow-through examination in 60 patients, double contrast enema in 50, surgery in 25 and endoscopy in 35. Statistical evaluation was carried out by χ² testing. For both techniques we have also calculated the effective dose and the equivalent dose in a standard patient. RESULTS: Crohn's disease was diagnosed in 64 patients, neoplasms in 16, adhesions in 6. Distension of the jejunum was better with CT-E than PEG-CT (p<0.05: statistically significant difference). No significant difference was present for others sites (p>0.05). Evaluation of pathological ileal loops was good with both techniques. The values of sensitivity, specificity and diagnostic accuracy were respectively 94%, 100% and 96% with CT-E, and 93%, 94% and 93% with PEG-CT. The effective dose for PEG-CT was less than the dose for the CT-E (34.7 mSv vs 39.91 mSv). CONCLUSION: PEG-CT shows findings of Crohn's disease as well as CT-E does, although CT-E gives better bowel distension, especially in the jejunum, and has higher specificity than PEG-CT.


Asunto(s)
Medios de Contraste , Fármacos Gastrointestinales , Enfermedades Inflamatorias del Intestino/diagnóstico por imagen , Intestino Delgado/diagnóstico por imagen , Polietilenglicoles , Adolescente , Adulto , Anciano , Medios de Contraste/administración & dosificación , Femenino , Fármacos Gastrointestinales/administración & dosificación , Humanos , Masculino , Persona de Mediana Edad , Polietilenglicoles/administración & dosificación , Sensibilidad y Especificidad , Tomografía Computarizada por Rayos X/métodos , Adulto Joven
7.
Radiol Med ; 114(7): 1141-58, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19774443

RESUMEN

PURPOSE: Percutaneous vertebroplasty (PVP) is a minimally invasive treatment for symptomatic vertebral compression fractures (VCFs). The aim of this study was to assess the effectiveness, complications and progress of results of PVP optimized in terms of technique, costs, time and strategic protocol after 3 years of procedures performed under fluoroscopic guidance alone. MATERIALS AND METHODS: We treated 250 VCFs in 120 consecutive patients after assessing clinical and radiological indications. The effectiveness of the procedure was determined by statistical analysis of numerical scores for pain, mobility and drug consumption before and after treatment. RESULTS: No major complications and only three minor complications occurred. Clinically relevant improved mobility and reduction of pain and analgesics were observed, with overall significant results (p<0.0001) in all patients at 24 h after PVP and in 83 available patients at 6 months. A total of five asymptomatic refractures of cemented vertebrae and 14 new symptomatic vertebral fractures at different levels were observed between 1 and 10 months after the procedure. CONCLUSIONS: PVP is a safe, rapid, effective and costeffective therapy for VCFs, requiring only brief hospital admission and with long-lasting clinical results, when performed under good-quality radiological guidance, when correct indications are respected and when it is associated with rehabilitation therapy in the follow-up. It is a valid alternative to conservative therapy, which is burdened by high healthcare costs and often requires long-term immobilisation of frail and elderly patients at risk of clinical complications.


Asunto(s)
Fracturas por Compresión/diagnóstico por imagen , Fracturas por Compresión/cirugía , Fotofluorografía , Radiografía Intervencional , Fracturas de la Columna Vertebral/diagnóstico por imagen , Fracturas de la Columna Vertebral/cirugía , Vertebroplastia/métodos , Anciano , Anciano de 80 o más Años , Cementos para Huesos/uso terapéutico , Femenino , Fijación Interna de Fracturas/métodos , Fracturas por Compresión/etiología , Fracturas por Compresión/terapia , Humanos , Masculino , Persona de Mediana Edad , Procedimientos Ortopédicos/métodos , Osteoporosis/complicaciones , Dimensión del Dolor/métodos , Fotofluorografía/métodos , Calidad de Vida , Reoperación , Estudios Retrospectivos , Medición de Riesgo , Fracturas de la Columna Vertebral/etiología , Fracturas de la Columna Vertebral/rehabilitación , Fusión Vertebral/métodos , Neoplasias de la Columna Vertebral/complicaciones , Columna Vertebral/diagnóstico por imagen , Columna Vertebral/cirugía , Resultado del Tratamiento
8.
Radiol Med ; 112(7): 1013-25, 2007 Oct.
Artículo en Inglés, Italiano | MEDLINE | ID: mdl-17952678

RESUMEN

PURPOSE: The aim of this study was to assess the diagnostic potential of multidetector computed tomography (MDCT) in the evaluation of small-bowel neoplasms. MATERIALS AND METHODS: We studied 120 patients with suspected small-bowel disease by 16-slice MDCT after oral administration of a polyethylene glycol solution (n=56) or methylcellulose via a nasojejunal tube (n=64). Unenhanced and contrast-enhanced CT was performed. Contrast-enhanced CT images were acquired 40 s after IV injection of 130 ml of iodinated contrast agent at a rate of 3 ml/s. Multiplanar reconstructions were performed at the end of the examinations. RESULTS: Fifteen patients were found to be affected by small-bowel neoplasm (six had non-Hodgkin's lymphoma, three had carcinoid tumour, two had Peutz-Jeghers syndrome, two had adenocarcinoma, two had melanoma metastases, one had lipoma). In the remaining patients, 58 cases of Crohn's disease and seven miscellaneous diseases were detected. All findings were confirmed by barium studies, surgery or endoscopy. CONCLUSIONS: MDCT performed after bowel-loop distension with low-density contrast material and IV administration of iodinated contrast agent is a reliable method for diagnosing and staging small-bowel neoplasms.


Asunto(s)
Adenocarcinoma/diagnóstico por imagen , Tumor Carcinoide/diagnóstico por imagen , Neoplasias del Íleon/diagnóstico por imagen , Neoplasias del Yeyuno/diagnóstico por imagen , Lipoma/diagnóstico por imagen , Linfoma no Hodgkin/diagnóstico por imagen , Síndrome de Peutz-Jeghers/diagnóstico por imagen , Tomografía Computarizada por Rayos X/métodos , Adenocarcinoma/patología , Administración Oral , Sulfato de Bario/administración & dosificación , Biopsia , Tumor Carcinoide/patología , Distribución de Chi-Cuadrado , Medios de Contraste/administración & dosificación , Enema , Femenino , Humanos , Neoplasias del Íleon/patología , Íleon/patología , Procesamiento de Imagen Asistido por Computador , Inyecciones Intravenosas , Neoplasias del Yeyuno/patología , Yeyuno/patología , Lipoma/patología , Linfoma no Hodgkin/patología , Masculino , Metilcelulosa/administración & dosificación , Síndrome de Peutz-Jeghers/patología , Polietilenglicoles/administración & dosificación , Intensificación de Imagen Radiográfica , Sensibilidad y Especificidad
9.
Blood ; 78(12): 3142-7, 1991 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-1742481

RESUMEN

Severe type II essential mixed cryoglobulinemia (EMC) bears a poor prognosis. Treatment with corticosteroids and/or cytotoxic drugs infrequently results in long-term remissions, and is associated with significant toxicity. We conducted a prospective study with interferon (IFN) in 21 patients with severe type II EMC unresponsive to immunosuppressive regimens. They were treated with recombinant IFN-alpha 2a (18 patients) or with natural IFN-beta (three patients), alone, at a dosage of 3 megaunits (MU)/d for 3 months, followed by 3 MU every other day as maintenance. We observed 11 complete remissions, five partial remissions, and five minor responses. Of 16 patients observed for more than 1 year, 11 remained in remission for 14 to 40 months; five of them remained in complete remission for 18 to 40 months after withdrawal of treatment. Four patients discontinued treatment because of side effects. In four patients who relapsed while on maintenance therapy with recombinant IFN-alpha 2a, remission could be reinduced by treatment with natural IFN-alpha. The response rate of 77% achieved in this study prompts the use of IFN-alpha as a first-choice drug for type II EMC.


Asunto(s)
Crioglobulinemia/terapia , Interferón-alfa/uso terapéutico , Adulto , Anciano , Anticuerpos/sangre , Resistencia a Medicamentos , Femenino , Humanos , Interferón alfa-2 , Interferón-alfa/administración & dosificación , Interferón-alfa/efectos adversos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Proteínas Recombinantes , Recurrencia , Inducción de Remisión
10.
Immunopharmacol Immunotoxicol ; 13(1-2): 87-100, 1991.
Artículo en Inglés | MEDLINE | ID: mdl-1770220

RESUMEN

During the last few years, several observations outline that the impaired T lymphocyte proliferative capacity in the elderly is due to a reduced interleukin 2 (IL-2) release. To further investigate the activation process during lectin stimulation, aged peripheral blood mononuclear cells (PBMC) were stimulated with phytohemagglutinin (PHA) and assessed for CD25 (IL-2 receptor) and CD71 (transferrin receptor) expression at different intervals of time. Our results provided evidence for a significant decline of both structure induction, above all in the later phase of culture. Indomethacin (INDO) treatment gave rise to an enhancement of CD71 antigen expression only, while prostaglandin E2 (PGE2) supplementation to culture media further decreased either CD25 or CD71 receptor induction. Interferon (IFN)-alpha and IFN-gamma treatment failed to modulate the frequency of CD25+ and/or CD71+ cells. Finally, the expression of CD71 receptor was increased by deferoxamine supplementation, this suggesting a partial involvement of iron overload in the depressed function. Although further studies are required to evaluate at a molecular level the decreased antigen expression, these findings indicate that several mechanism are involved in the elderly-related decline of T lymphocyte activation structures during lectin stimulation.


Asunto(s)
Envejecimiento/inmunología , Antígenos CD , Antígenos de Diferenciación de Linfocitos B , Receptores de Interleucina-2 , Linfocitos T/inmunología , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Técnicas In Vitro , Interferón-alfa/farmacología , Interferón gamma/farmacología , Activación de Linfocitos , Masculino , Fitohemaglutininas/inmunología , Receptores de Transferrina/inmunología
11.
Radiol Med ; 80(5): 656-60, 1990 Nov.
Artículo en Italiano | MEDLINE | ID: mdl-2267383

RESUMEN

From November 1989 to April 1990, 16 patients with rectal cancer were examined preoperatively by means of double contrast barium enema and defecography. Double contrast barium enema was used to identify the cancer: based on the distance of cancer from anal rima, the patients were divided into 3 groups: 1) less than 6 cm; 2) 6-11 cm; 3) more than 11 cm. In all patients defecography was performed at the end of barium enema to evaluate rectal wall mobility. Thus, the morphological information yielded by barium enema could be integrated with the dynamic data from defecography. The evaluation was thus possible of both longitudinal and, indirectly, transverse tumor spread. All the patients underwent surgery and radiological findings were compared with surgical ones. In those patients in whom defecography had shown rigidity of the rectal walls, extraparietal tumor spread was observed during surgical resection. Seven patients underwent anterior resection, and were subsequently examined by the same combination of barium enema and defecography. The combined use of the two methods was useful to evaluate the anastomosis and to show possible dynamic changes after surgery.


Asunto(s)
Defecación , Neoplasias del Recto/diagnóstico por imagen , Neoplasias del Recto/fisiopatología , Sulfato de Bario , Enema , Humanos , Periodo Posoperatorio , Cuidados Preoperatorios , Neoplasias del Recto/cirugía , Tomografía Computarizada por Rayos X
12.
Mech Ageing Dev ; 30(3): 251-9, 1985 May 31.
Artículo en Inglés | MEDLINE | ID: mdl-3160897

RESUMEN

T helper (Th) and T suppressor (Ts) functions on the induction of specific antibody response have been studied in 80 aged individuals by means of a plaque-forming cell assay. Of the subjects 45.2% exhibited a reduction of Ts activity on Ig production by adding Concanavalin A (Con A) to cultures on day 0, while 35.7% of aged donors showed a decrease of Th functions by supplementation of Con A on day 2. A small number of individuals displayed a combined deficit (Th + Ts). Furthermore, these defects seem to be related to soluble suppressive factors which might adhere to cell surface. In fact, preincubation of peripheral blood mononuclear cells (PBMC) before their addition to cultures and resuspension in fresh medium normalized the immunoregulatory defects. On the other hand, overnight supernatants from old PBMC transferred to young PBMC cultures induced the same deficit observed in the aged cell suspensions. Finally, Zinc chloride supplementation to cultures was able to correct the deficient Th activity only. These data suggest an additional defect of immunoregulation in the elderly.


Asunto(s)
Cloruros , Linfocitos T Colaboradores-Inductores/inmunología , Linfocitos T Reguladores/inmunología , Compuestos de Zinc , Adolescente , Adulto , Anciano , Envejecimiento , Células Cultivadas , Femenino , Técnica de Placa Hemolítica , Humanos , Indometacina/farmacología , Linfocitos/efectos de los fármacos , Masculino , Monocitos/efectos de los fármacos , Zinc/farmacología
13.
Br J Radiol ; 50(593): 340-9, 1977 May.
Artículo en Inglés | MEDLINE | ID: mdl-861453

RESUMEN

Scintigraphy of the adrenal gland with 131I-19-iodocholesterol has recently been added to radiological techniques in adrenal imaging and has been used successfully to demonstrate anatomical and functional disorders of the adrenals in a variety of clinical situations. A review of the authors' experience stresses the diagnostic value of this method. Radiological findings and results of scintillation imaging are complementary: their comparison improves and clarifes indications for scintigraphy. Hyperadrenal cortical diseases always gave satisfactory scintigrams, the most interesting results being obtained in adrenal cortical hyperplasia and unilateral hyperfunctioning adenomas. In these cases the evaluation of the response to stimulation or suppression tests was very useful. On the other hand scintigraphy was less valuable in demonstrating malignant and non malignant tumours.


Asunto(s)
Glándulas Suprarrenales/diagnóstico por imagen , Colesterol , Cintigrafía/métodos , Adenoma/diagnóstico , Neoplasias de la Corteza Suprarrenal/diagnóstico , Síndrome de Cushing/diagnóstico , Humanos , Radioisótopos de Yodo , Feocromocitoma/diagnóstico , Radiografía , Conteo por Cintilación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA